A multicancer early detection (MCED) test was developed and validated in the case-control Circulating Cell-free Genome Atlas (CCGA) study (ClinicalTrials.gov identifier: NCT02889978). Previous ...

The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny particles known as exosomes—is becoming increasingly realistic. Scientists ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Liquid biopsies look for cancer signals in the blood, and while the tests for early ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...

GRAIL IS AN American biotech company with an ambitious goal: to develop a blood test for the early detection of over 50 types of cancer. It will not be easy. On February 19th the company announced ...

A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including very small nodules that are often difficult to ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Some companies now offer multi-cancer early detection ...